The Federal Circuit opinion was authored by Judge Prost and joined by Judges Taranto and Hughes.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...
In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.